Loading...
Effects of Digoxin in Heart Failure (HF) With Reduced Ejection Fraction (EF)
Parikh, Riya R. Patel, Khushbu R. Pergolizzi, Joseph V. Breve, Frank Magnusson, Peter
Parikh, Riya R.
Patel, Khushbu R.
Pergolizzi, Joseph V.
Breve, Frank
Magnusson, Peter
Citations
Altmetric:
Genre
Journal article
Date
2022-03-02
Advisor
Committee member
Group
Department
Permanent link to this record
Collections
Research Projects
Organizational Units
Journal Issue
DOI
http://dx.doi.org/10.7759/cureus.22778
Abstract
In this review, we evaluated the literature on the benefits and deleterious effects of digoxin in heart failure (HF) with reduced ejection fraction (EF). Although digoxin was considered an effective treatment for HF, the supporting evidence is conflicting. Before the conventional use of modern HF therapies, digoxin was widely used for symptomatic relief on these patients. Further randomized trials are required to reach a definite conclusion about its efficacy and safety in patients experiencing HF with a reduced EF (HFrEF).
Description
Citation
Parikh R R, Patel K R, Pergolizzi J V, et al. (March 02, 2022) Effects of Digoxin in Heart Failure (HF) With Reduced Ejection Fraction (EF). Cureus 14(3): e22778. doi:10.7759/cureus.22778
Citation to related work
Springer
Has part
Cureus, Vol. 14
ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu